- Home
- RCKT vs HFRO Comparison
RCKT vs HFRO Comparison
Compare RCKT & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCKT | HFRO |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 406.7M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RCKT | HFRO |
|---|---|---|
| Price | $3.35 | $7.39 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.73 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 101.8K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | ★ 26.37 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | $5.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.53 | $5.47 |
| 52 Week High | $5.45 | $7.74 |
Technical Indicators
Market Signals| Indicator | RCKT | HFRO |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 59.50 |
| Support Level | $3.36 | $7.27 |
| Resistance Level | $3.65 | $7.55 |
| Average True Range (ATR) | 0.19 | 0.18 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 17.08 | 63.86 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.